# Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population

> **NCT03336593** · PHASE2 · COMPLETED · sponsor: **PT Bio Farma** · enrollment: 810 (actual)

## Conditions studied

- Safety Issues

## Interventions

- **BIOLOGICAL:** Quadrivalent Influenza Vaccine
- **BIOLOGICAL:** Trivalent Influenza Vaccine

## Key facts

- **NCT ID:** NCT03336593
- **Lead sponsor:** PT Bio Farma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-21
- **Primary completion:** 2018-03-14
- **Final completion:** 2018-11-30
- **Target enrollment:** 810 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03336593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03336593, "Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03336593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*